Acquisition & Growth As a company acquired by Stryker, Zippline Inc. benefits from a strong backing of a major player in medical devices, indicating potential opportunities for cross-selling or expanding within integrated healthcare solutions.

Innovative Portfolio Zippline’s recognition with the Red Herring Top 100 North America award highlights its position as an innovative leader in skin and wound closure, making it a valuable partner for hospitals and clinics seeking cutting-edge medical devices.

Funding Milestones With a substantial funding history totaling $44 million, Zippline demonstrates robust financial backing, supporting expansion efforts that can be leveraged to target healthcare providers focused on advanced surgical solutions.

Global Expansion Recent regional launches and CFDA approval for Zipline's skin closure device suggest opportunities to engage with international markets and medical suppliers seeking effective wound management products.

Technological Edge Zippline’s focus on noninvasive surgical skin closure and ongoing product development presents an opening to sell complementary medical equipment and services to providers investing in minimally invasive surgical techniques.